- Repligen Corporation (RGEN, Financial) will report its second quarter 2025 financial results on July 29, 2025.
- The earnings release will be before market opens, followed by a conference call at 8:30 a.m. ET.
- Investors can access the call via phone or webcast, with replays available afterward.
Repligen Corporation (RGEN), a leader in the life sciences industry, has announced it will release its financial results for the second quarter of 2025 on Tuesday, July 29. The announcement will take place before the market opens. Following the release, Repligen will host a conference call at 8:30 a.m. ET to discuss the results and provide updates on their business operations.
Investors interested in joining the conference call can do so by dialing (800) 715-9871 for domestic calls, or (646) 307-1963 for international calls. Additionally, a webcast will be available through Repligen’s Investor Relations website. Both the conference call and the webcast will be archived for future access, with replay available by calling (800) 770-2030 (US) or (609) 800-9909 (international), using passcode 7706699.
The financial results will cover the company's performance for both the three- and six-month periods ended June 30, 2025. Repligen Corporation, with headquarters in Waltham, Massachusetts, specializes in bioprocessing technologies that enhance the manufacturing of biological drugs, catering primarily to biopharmaceutical companies and CDMOs worldwide.
